Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure is a research paper published in Circulation (2020). On theSindex it has a DataRank of 0. It has been cited 78 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHLBI NIH HHS
Grant: R01 HL141232
NHLBI NIH HHS
Grant: K08 HL138262
NHLBI NIH HHS
Grant: R01 HL107594
NHLBI NIH HHS
Grant: R01 HL119962
NHLBI NIH HHS
Grant: R01 HL121510
NHLBI NIH HHS
Grant: R61 HL146390
NHLBI NIH HHS
Grant: RC2 HL102222
NHLBI NIH HHS
Grant: U10 HL110338
NHLBI NIH HHS
Grant: HHSN268201100026C
NIDDK NIH HHS
Grant: P30 DK056341
NHLBI NIH HHS
Grant: P01 HL094307
NHLBI NIH HHS
Grant: R01 HL104106
NHLBI NIH HHS
Grant: R56 HL136730
NHLBI NIH HHS
Grant: T32 HL007081
NIA NIH HHS
Grant: R01 AG058969
FWCI
3.28
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals